chr11-637485-A-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_000797.4(DRD4):āc.181A>Cā(p.Thr61Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000272 in 1,544,440 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_000797.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DRD4 | NM_000797.4 | c.181A>C | p.Thr61Pro | missense_variant | 1/4 | ENST00000176183.6 | NP_000788.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DRD4 | ENST00000176183.6 | c.181A>C | p.Thr61Pro | missense_variant | 1/4 | 1 | NM_000797.4 | ENSP00000176183 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152050Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000202 AC: 3AN: 148602Hom.: 0 AF XY: 0.0000249 AC XY: 2AN XY: 80218
GnomAD4 exome AF: 0.0000244 AC: 34AN: 1392390Hom.: 0 Cov.: 32 AF XY: 0.0000276 AC XY: 19AN XY: 687914
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152050Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74292
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2021 | The c.181A>C (p.T61P) alteration is located in exon 1 (coding exon 1) of the DRD4 gene. This alteration results from a A to C substitution at nucleotide position 181, causing the threonine (T) at amino acid position 61 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at